Results per Page:

Menopausal hormone therapy may lower the risk of colorectal cancer
From the Peters and Hsu Groups, Cancer Consortium & Public Health Sciences Division

3 new grants power colorectal cancer studies
Research will focus on CRC in Alaska Native people, gene + environment interactions and how systemic racism impacts care

New study of Asian, Native Hawaiian and Pacific Islander populations gets $38.7M grant
Fred Hutch will act as coordinating center for large study of cardiovascular and other chronic diseases in overlooked populations

Predicting colorectal cancer risk in a community-based cohort
From the Hsu Group, Public Health Sciences Division at Fred Hutch, and Kaiser Permanente Washington Health Research Institute

Homing in on inherited colorectal cancer risk
Hutch-led international collaboration finds 100 new genetic risk variants, setting the stage for better prevention for all

Uncovering colorectal cancer risk factors lurking in the genome
From the Peters and Hsu Groups, Public Health Sciences Division

Study unveils 40 new mutations linked to colorectal cancer
Q&A: Dr. Riki Peters on what this large genome-wide association study means for patients and the public

Colorectal cancer risk meets precision medicine
From the Peters and Hsu Groups, Public Health Sciences Division

A roadmap for precision colorectal cancer screening
New study combines environmental, lifestyle and genetic information to create a more nuanced risk-prediction model

Progress in ‘precision prevention’ for colorectal cancer
New risk prediction model — not yet ready for clinical use — incorporates genetic, lifestyle and environmental risk factors

Does aspirin prevent colorectal cancer? Depends on your DNA
Fred Hutch researchers move closer to cracking the code on how genes and environmental factors influence colorectal cancer risk

Gene-diet interactions may be responsible for colorectal cancer risk in red meat-eaters
A new study identifies two genetic variants that may determine one’s risk for the disease

Four gene variants associated with increased colorectal cancer risk identified
Fred Hutchinson Cancer Research Center’s Riki Peters, Li Hsu lead international genomewide-association study, pointing to potential drug targets, top screening beneficiaries